Please log in to see the full text of this API!

Telmisartan

  • Synonyms: BIBR 277, BIBR 277SE
  • ATC: C09CA07
  • Use: Lorem  Lorem 
  • Chemical name: Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
  • Formula: Lorem ipsum dolor sit amet,
  • MW:514.63 g/mol
  • CAS-RN:144701-48-4
  • InChI Key:RMMXLENWKUUMAY-UHFFFAOYSA-N
  • InChI:InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)

Substance Classes

Synthesis Path












Substances Referenced in Synthesis Path

CAS-RN Formula Chemical Name CAS Index Name
114772-40-6 C18H19BrO2 tert-butyl 4'-(bromomethyl)biphenyl-2-carboxylate [1,1'-Biphenyl]-2-carboxylic acid, 4'-(bromomethyl)-, 1,1-dimethylethyl ester
141-75-3 C4H7ClO butyryl chloride Butanoyl chloride
144702-26-1 C37H38N4O2 4'-[[1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]-[1,1'-biphenyl]-2-carboxylic acid 1,1-dimethylethyl ester [1,1'-Biphenyl]-2-carboxylic acid, 4'-[[1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]-, 1,1-dimethylethyl ester
18595-14-7 C9H11NO2 methyl 4-amino-3-methylbenzoate Benzoic acid, 4-amino-3-methyl-, methyl ester
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem

Trade Names

Country Trade Name Vendor Annotation
D Lorem Lorem comb.
Lorem Lorem
Lorem Lorem
Lorem ipsum Lorem comb.
F Lorem Lorem
Lorem ipsum Lorem
Lorem Lorem
Lorem ipsum Lorem
GB Lorem Lorem
I Lorem Lorem
Lorem Lorem
J Lorem Lorem Lorem
USA Lorem ipsum Lorem
(wfm = withdrawn from market)

Formulations

  • Loremipsumdolorsitamet,consetetursadipscingelitr,seddiam

References

    • Ries, U. et al.: J. Med. Chem. (JMCMAR) 36, 4040-4051 (1993).
    • US 9 999 999 (Thomae; 7.1.1997; D-prior. 6.2.1991, 25.5.1991, 16.11.1991, 22.1.1992, 11.4.1992, 17.6.1992, 22.7.1992, 27.7.1992, 4.8.1992).
    • EP 999 999 (Thomae; 9.9.1992; appl. 31.1.1992; D-prior. 6.2.1991).
    • DE 9 999 999 (Thomae; 21.9.1995; appl. 14.3.1994; D-prior. 14.3.1994).
  • use for the treatment of a condition associated with hypoxia or unpaired metabolic function:

    • WO 9 999 999 (Eurogene Ltd.; appl. 19.10.1998; GB-prior. 17.10.1997).
  • use to treat symptomatic heart failure:

    • WO 9 999 999 (Merck & Co.; appl. 7.1.1998; USA-prior. 10.1.1997).
  • method to treat cardiofibrosis with a combination of an ATII-antagonist and spironolactone:

    • WO 9 999 999 (G. D. Searle; appl. 5.6.1996; USA-prior. 7.6.1995).